Brentuximab Vedotin Administered Before, During, and After Multi-Agent Chemotherapy In Patients (pts) With Newly-Diagnosed CD30+ Mature T- and NK-Cell Lymphomas
Year: 2013
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, University of Alabama at Birmingham, Washington University in St. Louis, Stanford Medicine, Stanford University, Thomas Jefferson University Hospital, City Of Hope National Medical Center, University Hospital Southampton NHS Foundation Trust, The Christie Hospital, Takeda Oncology (United States), Seagen (United States), University of Washington
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W78672495